Study guide

5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

Key Takeaways Explain This Topic AI

In severe asthma, a falling respiratory rate, quiet chest, altered mental status, or rising/normalizing PaCO2 despite persistent distress can signal exhaustion and impending respiratory failure.

In cystic fibrosis, combine airway-surface hydration, individualized airway clearance, dornase alfa, inhaled antibiotics when indicated, nutrition, and culture-directed exacerbation treatment in the prescribed sequence.

Sudden focal wheeze or unilateral air trapping suggests foreign-body aspiration; rigid bronchoscopy is the definitive diagnostic and therapeutic procedure when suspicion is high.

Last updated: September 2026

  • 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration
  • Pediatric Asthma Exacerbation & Status Asthmaticus

Asthma is a chronic inflammatory disorder characterized by bronchial hyperreactivity and episodic, reversible airflow obstruction. Severe acute exacerbation unresponsive to initial bronchodilator therapy is termed status asthmaticus .

Pathophysiological Triad

Acute Bronchospasm: Contraction of hypertrophied bronchial smooth muscle triggered by allergens, viral respiratory infections, cold air, or exercise.

Airway Wall Edema: Microvascular leakage, inflammatory cellular infiltration (eosinophils, mast cells, T-lymphocytes), and mucosal swelling.

Intraluminal Mucus Hypersecretion: Tenacious, viscous mucus plugging of small conducting airways.

The Blood Gas Progression in Acute Asthma

Understanding arterial blood gas (ABG) evolution in acute asthma is paramount on the NPS specialty examination: +-------------------------------------------------------------------------------------------------------------+

| BLOOD GAS EVOLUTION IN PEDIATRIC ASTHMA |

+---------------------+-----------------------+---------------------------------------------------------------+

| Stage | ABG Pattern | Clinical Correlation & Mechanistic Interpretation |

+---------------------+-----------------------+---------------------------------------------------------------+

  • | Early / Mild | Low PaO2, Low PaCO2, | Hyperventilation: hypoxemia drives tachypnea. Excessive |
  • | Exacerbation | High pH (Resp Alk) | minute ventilation blows off CO2 (PaCO2 25-34 mmHg). |

+---------------------+-----------------------+---------------------------------------------------------------+

  • | Impending Failure | Low PaO2, NORMAL | CO2 Retention Imminent: Patient is fatiguing. Despite |
  • | (OMINOUS TRANSITION)| PaCO2 (38-42 mmHg), | persistent tachypnea and marked retractions, the PaCO2 has |
  • | | Normal pH (~7.40) | 'normalized'. Signals diaphragmatic exhaustion and imminent |
  • | | | ventilatory failure. |

+---------------------+-----------------------+---------------------------------------------------------------+

  • | Decompensated | Marked Hypoxemia, | Terminal Failure: Diaphragmatic arrest, severe hypercapnia |
  • | Respiratory Failure | HIGH PaCO2 (>45-50), | with mixed respiratory and lactic acidosis. Requires immediate|
  • | | Severe Acidosis (<7.30)| noninvasive or invasive ventilatory intervention. |

+---------------------+-----------------------+---------------------------------------------------------------+

Emergency Pharmacological Escalation Ladder

Inhaled Short-Acting β 2 \beta_2 β 2 ​ -Agonists (SABA):

Albuterol: Dosed via metered-dose inhaler with valved holding chamber (4 to 8 puffs every 20 minutes) or nebulized solution ( 2.5 to 5.0 mg 2.5\text{ to }5.0\text{ mg} 2.5 to 5.0 mg every 20 minutes for 3 doses). For severe distress, initiate continuous albuterol nebulization at 10 to 20 mg/hr 10\text{ to }20\text{ mg/hr} 10 to 20 mg/hr .

Inhaled Anticholinergics:

Ipratropium Bromide: Administered as 0.25 mg 0.25\text{ mg} 0.25 mg (child < 20 kg <20\text{ kg} < 20 kg ) or 0.50 mg 0.50\text{ mg} 0.50 mg (child > 20 kg >20\text{ kg} > 20 kg ) combined with albuterol every 20 minutes for the first 3 doses. Blocks muscarinic cholinergic receptors, reducing bronchomotor tone and drying mucus secretions.

Systemic Corticosteroids:

Oral Dexamethasone 0.6 mg/kg 0.6\text{ mg/kg} 0.6 mg/kg (maximum 16 mg 16\text{ mg} 16 mg ) daily for 2 days, or oral Prednisolone 1 to 2 mg/kg/day 1\text{ to }2\text{ mg/kg/day} 1 to 2 mg/kg/day , or IV Methylprednisolone 1 to 2 mg/kg 1\text{ to }2\text{ mg/kg} 1 to 2 mg/kg every 6 hours . Blunts the inflammatory cascade, up-regulates β 2 \beta_2 β 2 ​ -receptor expression, and prevents late-phase relapse.

Intravenous Magnesium Sulfate:

Dosing: 25 to 50 mg/kg 25\text{ to }50\text{ mg/kg} 25 to 50 mg/kg IV (maximum 2.0 g 2.0\text{ g} 2.0 g ) infused over 20 to 30 minutes 20\text{ to }30\text{ minutes} 20 to 30 minutes .

Mechanism: Inhibits calcium influx into bronchial smooth muscle cells, blocks neuromuscular acetylcholine transmission, and promotes direct bronchodilation. Monitor for transient hypotension and facial flushing.

Intravenous Terbutaline:

Continuous IV β 2 \beta_2 β 2 ​ -agonist infusion: Bolus 2 to 10 mcg/kg 2\text{ to }10\text{ mcg/kg} 2 to 10 mcg/kg over 10 minutes, followed by continuous infusion at 0.1 to 1.0 mcg/kg/min 0.1\text{ to }1.0\text{ mcg/kg/min} 0.1 to 1.0 mcg/kg/min (titrated up to 2 − 4 mcg/kg/min 2-4\text{ mcg/kg/min} 2 − 4 mcg/kg/min ). Indicated when dense air trapping and minimal tidal excursion prevent inhaled aerosols from depositing in distal airways.

Heliox Therapy (Helium-Oxygen Mixture):

Mixtures: 80:20 (factor 1.8 1.8 1.8 ) or 70:30 (factor 1.6 1.6 1.6 ). Helium has a density one-third that of nitrogen, dramatically lowering Reynolds number and transforming turbulent airflow into smooth laminar flow across narrowed airways, reducing work of breathing and enhancing particle deposition.

Noninvasive Positive Pressure Ventilation (BiPAP):

Dosed with IPAP 10 to 14 cmH 2 O 10\text{ to }14\text{ cmH}_2\text{O} 10 to 14 cmH 2 ​ O and EPAP 4 to 6 cmH 2 O 4\text{ to }6\text{ cmH}_2\text{O} 4 to 6 cmH 2 ​ O . Offloads fatigued inspiratory muscles, stents open dynamic airways, and recruits microatelectatic zones, frequently avoiding invasive intubation.

Foreign Body Aspiration (FBA)

Foreign body aspiration is a major cause of accidental pediatric mortality, predominantly occurring in children between 1 and 3 years of age due to oral exploratory behavior, lack of molar teeth for grinding, and uncoordinated chewing/swallowing.

Pathophysiology & Anatomical Predisposition

Common Objects: Organic foodstuffs (peanuts, seeds, raw carrots, hot dog rounds) and small toy parts or coins. Peanuts and oily nuts release organic free fatty acids, triggering intense local chemical bronchitis and granulation tissue.

Anatomical Site: The right mainstem bronchus is the most frequent site of lodgment due to its slightly larger caliber, more direct vertical alignment, and greater airflow distribution.

Airway Obstruction Dynamics:

Bypass Valve: Partial obstruction allowing air to enter and exit; causes local wheezing.

Ball-Valve Obstruction: The airway expands during inspiration, allowing air to bypass the foreign body, but constricts during expiration, trapping air distally. Produces dynamic obstructive emphysema (hyperinflation) .

Stop-Valve Obstruction: Complete occlusion preventing any airflow; alveolar air distal to the obstruction is resorbed, causing complete absorption atelectasis .

Clinical Presentation & Imaging

Clinical Triad: The classic triad consists of: 1) Sudden, witnessed choking/coughing episode, 2) Unilateral monophonic wheeze, and 3) Asymmetric, decreased breath sounds. (Note: The triad is present in < 60 % <60\% < 60% of cases; a clear history of sudden choking is sufficient to mandate investigation).

Radiographic Imaging:

Standard chest X-rays miss most organic foreign bodies because food items are radiolucent .

Inspiratory and Expiratory CXR (or Bilateral Lateral Decubitus Views in Infants): During expiration (or when the child is placed in the lateral decubitus position with the affected lung down), the normal lung deflates and becomes smaller. The obstructed lung, however, exhibits air trapping: failure to collapse, persistent hyperlucency, and mediastinal shift away from the affected side .

Emergency & Definitive Management

Acute Choking Emergency (BLS Protocol):

Infant ( < 1 year <1\text{ year} < 1 year ): Deliver 5 firm back blows (slaps) between the scapulae, followed by 5 downward chest thrusts . Repeat until object is dislodged or infant becomes unconscious.

Child ( > 1 year >1\text{ year} > 1 year ): Perform series of subdiaphragmatic abdominal thrusts (Heimlich maneuver) .

ABSOLUTE RULE: NEVER perform a blind finger sweep. Blind sweeping easily pushes a movable supraglottic foreign body deeper into the laryngeal aperture, causing complete obstruction.

Definitive Extraction:

Bronchoscopic removal is the definitive approach for most aspirated airway foreign bodies. Rigid bronchoscopy commonly provides airway control and a large working channel; flexible bronchoscopy can be diagnostic and, in selected centers and objects, therapeutic. Choose technique and location with the pediatric airway and bronchoscopy team.

Worked Calculation: Heliox Flowmeter Conversion

Heliox gas mixtures have a lower physical density than 100% oxygen. Because standard hospital flowmeters are calibrated specifically for 100 % O 2 100\%\text{ }\text{O}_2 100% O 2 ​ , they deliver a higher volume of heliox gas than the scale indicates. To calculate actual flow delivered: Actual Flow Delivered = Observed Flowmeter Reading × Heliox Factor \text{Actual Flow Delivered} = \text{Observed Flowmeter Reading} \times \text{Heliox Factor} Actual Flow Delivered = Observed Flowmeter Reading × Heliox Factor

For an 80:20 Heliox mixture , the conversion factor is 1.8 1.8 1.8 .

For a 70:30 Heliox mixture , the conversion factor is 1.6 1.6 1.6 .

Worked Example

A respiratory therapist is delivering an 80:20 heliox mixture via a non-rebreather mask to a 6-year-old child in severe status asthmaticus. The oxygen flowmeter is currently set at an indicated reading of 10 L/min 10\text{ L/min} 10 L/min .

Calculate the actual flow rate delivered to the patient: Actual Flow = 10 L/min × 1.8 = 18 L/min \text{Actual Flow} = 10\text{ L/min} \times 1.8 = 18\text{ L/min} Actual Flow = 10 L/min × 1.8 = 18 L/min

If the clinician desires to deliver an actual flow of 14.4 L/min 14.4\text{ L/min} 14.4 L/min using a 70:30 heliox mixture, what should the flowmeter be set to? Indicated Flow = Desired Actual Flow Heliox Factor = 14.4 L/min 1.6 = 9 L/min \text{Indicated Flow} = \frac{\text{Desired Actual Flow}}{\text{Heliox Factor}} = \frac{14.4\text{ L/min}}{1.6} = 9\text{ L/min} Indicated Flow = Heliox Factor Desired Actual Flow ​ = 1.6 14.4 L/min ​ = 9 L/min

  • NPS Exam Traps
  • Exam Trap 1: The 'Normal' PaCO2 in Severe Pediatric Asthma

In an asthmatic child exhibiting marked tachypnea, severe suprasternal retractions, and agitation, a 'normal' PaCO 2 \text{PaCO}_2 PaCO 2 ​ of 38 to 42 mmHg 38\text{ to }42\text{ mmHg} 38 to 42 mmHg on arterial blood gas is NOT reassuring . A tachypneic child should be blowing off carbon dioxide ( PaCO 2 < 32 to 35 mmHg \text{PaCO}_2 < 32\text{ to }35\text{ mmHg} PaCO 2 ​ < 32 to 35 mmHg ). A 'normal' PaCO 2 \text{PaCO}_2 PaCO 2 ​ indicates the child's diaphragm is exhausting; ventilatory failure and respiratory arrest are imminent. The correct action is immediate escalation (continuous albuterol, IV magnesium sulfate, BiPAP, or PICU transfer), not de-escalation.

Exam Trap 2: The Tongue Depressor in Epiglottitis

High fever, drooling, toxic appearance, tripod position, and stridor suggest a precarious supraglottic airway. Keep the child calm and upright, avoid forceful pharyngeal examination or nonessential procedures, and mobilize experienced pediatric anesthesia/airway and ENT clinicians in a setting with a complete difficult-airway and surgical-rescue plan. Do not let imaging or cultures delay control of a deteriorating airway.

Exam Trap 3: Bronchodilators and Steroids in Viral Bronchiolitis

Exam vignettes often present an infant with tachypnea, wheezing, and RSV bronchiolitis. Distractors will include 'nebulized albuterol every 20 minutes' or 'oral dexamethasone'. Based on AAP guidelines, bronchodilators and corticosteroids are not indicated for routine viral bronchiolitis . Select supportive care: superficial suctioning, hydration, and heated high-flow nasal cannula (HFNC).